NaturalNano Inc. (NNAN) leaps on new drug presentation
Posted on: August 24th, 2011Written by:
NaturalNano Inc. (OTCBB: NNAN) shares triumphed 33.3% to two-10ths of a cent Wednesday morning, on news that breakthroughs for the company’s cancer treatment. Volume for the stock measured 29.1 million shares.
A news release issued August 24 had the Rochester, New York-based NaturalNano announcing today that Dr. Michael King of Cornell University will present his recent work today at the Cancer Summit in Washington.
His presentation will demonstrate the capture of circulating tumor cells (CTCs) in blood can be targeted more effectively by incorporation of NaturalNano’s Halloysite Natural Tubes (HNT) onto the surface of devices used to capture CTCs in blood.
Dr. King, an Associate Professor of biomedical engineering at Cornell University, was quoted thus in the press release: “The ability to create stable coatings of Halloysite Natural Tubes (HNT) using an extremely thin layer of poly-L-lysine allows the creation of nanostructured surfaces to which living cells respond.”
King continued, “The nanotubes with HNT incorporated into their surface were found to enhance the natural CTC rolling mechanism. This allows the cells to be exposed to specific therapeutic agents or isolated and collected for diagnostic and research purposes.”
NaturalNano, Inc.is a materials science company focused on developing and commercializing advanced nanocomposites.
